In case you didn’t know about Vivek Ramaswamy’s company Genevant….
‘Our unique capabilities…
Companies in the nucleic acid space typically work with only a singular modality, such as mRNA, siRNA or gene editors. Our multiple platforms provide the ability to exploit multiple constructs, and our technology is validated by the field-based licenses that we have granted to industry leaders.’
www.genevant.com/our-technology/
‘Our unique capabilities…
Companies in the nucleic acid space typically work with only a singular modality, such as mRNA, siRNA or gene editors. Our multiple platforms provide the ability to exploit multiple constructs, and our technology is validated by the field-based licenses that we have granted to industry leaders.’
www.genevant.com/our-technology/
In case you didn’t know about Vivek Ramaswamy’s company Genevant….
‘Our unique capabilities…
Companies in the nucleic acid space typically work with only a singular modality, such as mRNA, siRNA or gene editors. Our multiple platforms provide the ability to exploit multiple constructs, and our technology is validated by the field-based licenses that we have granted to industry leaders.’
www.genevant.com/our-technology/
0 Comments
0 Shares
1347 Views
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek